Molecularly Targeted Radionuclide Therapy Via the Integrin Alphavbeta6
Molecularly Targeted Radionuclide Therapy Via the Integrin Alphavbeta6
Recruiting · NCT06228482 · Registry updated 2026-02-27Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Molecularly Targeted Radionuclide Therapy Via the Integrin Alphavbeta6 | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Recruiting | Phase 1 | 2026-02-27 | NCT06228482 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| United States Department of Defense | 319 |
| University of California, Davis | 257 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| The University of California Davis Comprehensive Cancer Center | Sacramento | United States | 3 |